No takes yet. Share an insight, caveat, or question.
Randomized trial evaluates the role of mitoK(ATP) channels in reducing apoptosis in cardiac cells, suggesting therapeutic potential.
Akao et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: